Patent · US Active

Use of neuropeptides for ligament healing

US7776815B2 · kind B2 · utility

15Cited by
3References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 23, 2005
Grant dateAug 17, 2010
Priority date—
Expiry dateMay 25, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/2278
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are a method and a corresponding pharmaceutical composition for treating damaged ligaments. Neurogenic compounds in general and neuropeptides in particular have been found to be highly effective in stimulated repair of ligaments damaged due to traumatic injury, ligament disease, and disuse. Preferred active ingredients for use in the method and corresponding pharmaceutical composition include calcitonin gene-related peptide (CGRP), cholecystokinin (CCK), dynorphin, enkephalin, galanin, neuropeptide Y (NPY), neurotensin, somatostatin, substance P (SP), thyrotropin-releasing hormone (TRH), vasoactive intestinal peptide (VIP).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.